Clinical Trial: Efficacy and Safety of Prophylactic Antibiotics in Preventing Ventilator-associated Pneumonia: A Randomized, Double Blind, Placebo-controlled Trial

U.S., Oct. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07203638) titled 'Efficacy and Safety of Prophylactic Antibiotics in Preventing Ventilator-associated Pneumonia: A Randomized, Double Blind, Placebo-controlled Trial' on Sept. 25.

Brief Summary: Evaluate efficacy and safety of prophylactic antibiotics in preventing early ventilator-associated pneumonia

Study Start Date: Nov. 01, 2024

Study Type: INTERVENTIONAL

Condition: Ventilator-Associated Pneumonia (VAP)

Intervention: DRUG: Beta Lactam Antibiotics

Beta lactam cefipim infusion (20mg/kg -12h -2 days ) total volume 10 ml

DRUG: Salin

Patient will receive .9 % saline (10ml /12h/2days)

Recruitment Status: ENROLLING_BY_INVITATION

Sponsor: Esra...